Abstract
Fistulae are distressing chronic complications of Crohn's disease which have served as one of the most common indications for surgical resection. While steroids and sulfasalazine have not been successful in closing fistulae, in a previous double-blind study 6-mercaptopurine (6-MP) was more effective than placebo in accomplishing this goal (31% vs 6%). Thirty-four patients with Crohn's disease fistulae were treated with 6-MP for a minimum period of 6 months. In 13 patients (39%) the fistulae closed completely, and in another 9 (26%) there was obvious improvement. All types of fistulae responded to 6-MP with the most impressive closures occurring in patients with fistulae of the abdominal wall and enteroenteric fistulae. The mean time to respond was 3.1 months, with 23% of patients taking longer than 4 months to show any response. Response was not related to other drugs (steroids, sulfasalazine) used in conjunction with the 6-MP. The site of intestinal involvement with Crohn's disease did not appear to play a significant role in the frequency or degree of response to 6-MP, but patients without prior resection and fistulae did better than those with fistulae occurring after surgery. The long-term response to fistulae was good if 6-MP was maintained, whereas exacerbation eventually followed discontinuation of 6-MP. 6-Mercaptopurine is an effective and useful drug in the treatment of fistulae, as it is in other manifestations of chronic unrelenting Crohn's disease.
Similar content being viewed by others
References
Farmer RG, Hawk WA, Turnbull RB Jr: Indications for surgery in Crohn's disease. Gastroenterology 71:245–250, 1976
Farmer RG, Whelan G, Fazio VW: Does the indication for surgery and the clinical pattern at presentation determine the relapse rate in patients with Crohn's disease? Gastroenterology 78(Part 2):1163, 1980
Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS: Treatment of Crohn's disease with 6-mercaptopurine. N Engl J Med 302:981–987, 1980
Steinberg DM, Cooke WT, Alexander-Williams J: Abscess and fistulae in Crohn's disease. Gut 14:865–869, 1973
Moss AA, Carbone JV, Kressel HY: Radiologic and clinical assessment of broad spectrum antibiotic therapy in Crohn's disease. Am J Roentgenol 131:787–790, 1978
Bernstein LH, Frank MS, Brandt LJ, Boley SJ: Healing of perineal Crohn's disease with metronidazole. Gastroenterology 79:357–365, 1980
Elson CO, Layden TJ, Nemchausky BA, Rosenberg JL, Rosenberg IH: An evaluation of total parenteral nutrition in the management of inflammatory bowel disease. Dig Dis Sci 25:42–48, 1980
Brooke BN, Cave DR, Gurry JF, King DW: Crohn's Disease—Aetiology, Clinical Manifestations and Management. New York, Oxford University Press, 1977
Alexander-Williams J: Surgery and the management of Crohn's disease. Clin Gastroenterol 2:469–491, 1972
Alexander-Williams J, Buchman P: Perianal Crohn's disease. World J Surg 4:203–208, 1980
Rankin GB, Watts HD, Melnyk CS, Kelley ML Jr: National Cooperative Crohn's Disease Study: Extraintestinal manifestations and perianal complications. Gastroenterology 77:914–920, 1979
Sohn N, Korelitz BI, Weinstein MA: Crohn's disease: definitive surgery for fistulae and recurrent abscesses. Am J Surg 139:394–397, 1980
Broe PJ, Bayless TM, Cameron JL: Crohn's disease: Are enteroenteral fistulas an indication for surgery? Surgery 91:249–253, 1982
Greenstein AJ, Kark AE, Dreiling DA: Crohn's disease of the colon. I. Fistula in Crohn's disease of the colon; classification, presenting features and management in 63 patients. Am J Gastroenterol 62:419–429, 1974
Winkelman EI, Brown CH: Nitrogen mustard in the treatment of chronic ulcerative colitis and regional enteritis: a preliminary report. Cleve Clin Q 32:165–174, 1965
Brooke BN, Hoffman DC, Swarbrick ET: Azathioprine for Crohn's disease. Lancet 2:612–614, 1969
Brooke BN, Javett SL, Davison OW: Further experience with azathioprine for Crohn's disease. Lancet 2:1050–1053, 1970
Brown CH, Achkar E: Azathioprine therapy for inflammatory bowel disease: A preliminary report. Am J Gastroenterol 54:363–377, 1970
Drucker WR, Jeejeebhoy KN: Azathioprine—an adjunct to surgical therapy of granulomatous enteritis. Ann Surg 172:618–625, 1970
Javett SL: Azathioprine in Crohn's disease. Clin Gastroenterol 1:507–520, 1972
Brooke BN, Cave DR, Gurry JF, King DW: Crohn's Disease. New York: Oxford University Press, 1977
Rhodes J, Bainton D, Beck P: Azathioprine in Crohn's disease. Lancet 2:1273–1276, 1971
Patterson JF, Norton RA, Schwartz RS: Azathioprine treatment of ulcerative colitis, granulomatous colitis and regional enteritis. Am J Dig Dis 16:327–332, 1971
Klein M, Binder HJ, Mitchell M, Aaronson R, Spiro H: Treatment of Crohn's disease with azathioprine: A controlled evaluation. Gastroenterology 66:916–922, 1974
Korelitz BI: Therapy of inflammatory bowel disease including use of immunosuppressive agents. Clin Gastroenterol 9:331–349, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Korelitz, B.I., Present, D.H. Favorable effect of 6-Mercaptopurine on fistulae of Crohn's disease. Digest Dis Sci 30, 58–64 (1985). https://doi.org/10.1007/BF01318372
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01318372